INmune Bio Inc.

NASDAQ: INMB · Real-Time Price · USD
7.35
-0.67 (-8.35%)
At close: Jun 17, 2025, 3:10 PM

INmune Bio Revenue

INmune Bio reported an annual revenue of $14K, reflecting a -90.97% growth. For the quarter ending March 31, 2025, INmune Bio generated $50K in revenue.
Revenue (ttm)
$14K
Revenue Growth
-90.97%
Price / Sales Ratio
6652.85
Revenue / Employee
$1.08K
Employees
13
Market Cap
170.6M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.